211 related articles for article (PubMed ID: 27899617)
1. Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains.
Gao Y; Teschendorff AE
Nucleic Acids Res; 2017 Jan; 45(2):583-596. PubMed ID: 27899617
[TBL] [Abstract][Full Text] [Related]
2. An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.
Yang Z; Jones A; Widschwendter M; Teschendorff AE
Genome Biol; 2015 Jul; 16(1):140. PubMed ID: 26169266
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
4. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
Wang J; Liu Q; Shyr Y
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S5. PubMed ID: 26100984
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms involved in epigenetic alterations in cancer].
Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
[TBL] [Abstract][Full Text] [Related]
7. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
9. Mining the epigenetic landscape of tissue polarity in search of new targets for cancer therapy.
Atrian F; Lelièvre SA
Epigenomics; 2015; 7(8):1313-25. PubMed ID: 26646365
[TBL] [Abstract][Full Text] [Related]
10. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
11. Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors.
Hesson LB; Ng B; Zarzour P; Srivastava S; Kwok CT; Packham D; Nunez AC; Beck D; Ryan R; Dower A; Ford CE; Pimanda JE; Sloane MA; Hawkins NJ; Bourke MJ; Wong JW; Ward RL
Mol Cancer Res; 2016 Dec; 14(12):1217-1228. PubMed ID: 27671336
[TBL] [Abstract][Full Text] [Related]
12. Regional copy number-independent deregulation of transcription in cancer.
Stransky N; Vallot C; Reyal F; Bernard-Pierrot I; de Medina SG; Segraves R; de Rycke Y; Elvin P; Cassidy A; Spraggon C; Graham A; Southgate J; Asselain B; Allory Y; Abbou CC; Albertson DG; Thiery JP; Chopin DK; Pinkel D; Radvanyi F
Nat Genet; 2006 Dec; 38(12):1386-96. PubMed ID: 17099711
[TBL] [Abstract][Full Text] [Related]
13. Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines.
Li SD; Tagami T; Ho YF; Yeang CH
BMC Syst Biol; 2011 Nov; 5():186. PubMed ID: 22051105
[TBL] [Abstract][Full Text] [Related]
14. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
15. Cancerous perturbations within the ERK, PI3K/Akt, and Wnt/β-catenin signaling network constitutively activate inter-pathway positive feedback loops.
Padala RR; Karnawat R; Viswanathan SB; Thakkar AV; Das AB
Mol Biosyst; 2017 May; 13(5):830-840. PubMed ID: 28367561
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes in cancer.
Iacobuzio-Donahue CA
Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.
Zhang J; Huang K
BMC Genomics; 2017 Jan; 18(Suppl 1):1045. PubMed ID: 28198667
[TBL] [Abstract][Full Text] [Related]
18. Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development.
Chen Y; Widschwendter M; Teschendorff AE
Genome Biol; 2017 Dec; 18(1):236. PubMed ID: 29262847
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drivers of genetic alterations.
Toyota M; Suzuki H
Adv Genet; 2010; 70():309-23. PubMed ID: 20920753
[TBL] [Abstract][Full Text] [Related]
20. Tensorial blind source separation for improved analysis of multi-omic data.
Teschendorff AE; Jing H; Paul DS; Virta J; Nordhausen K
Genome Biol; 2018 Jun; 19(1):76. PubMed ID: 29884221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
